These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications.
    Author: Ahn JY, Jung HY, Choi KD, Choi JY, Kim MY, Lee JH, Choi KS, Kim DH, Song HJ, Lee GH, Kim JH, Park YS.
    Journal: Gastrointest Endosc; 2011 Sep; 74(3):485-93. PubMed ID: 21741645.
    Abstract:
    BACKGROUND: Current guidelines for endoscopic management such as EMR and endoscopic submucosal dissection (ESD) in early gastric cancer (EGC) are in evolution, with broader indication criteria. OBJECTIVE: To determine the clinical outcomes of endoscopic treatment, based on absolute indication and extended indication criteria and endoscopic methods. DESIGN: Retrospective study. SETTING: Tertiary-care, academic medical center. PATIENTS: EMR or ESD was performed on 1627 cases of EGC in 1447 patients from July 1994 to January 2009. INTERVENTION: EMR and ESD. MAIN OUTCOME MEASUREMENTS: Clinical outcomes of EGC after EMR or ESD, based on the indication criteria. RESULTS: Although the complete resection rate was higher (95.9% vs 88.4%; P < .001), and the complication rate was lower (6.8% vs 9.8%; P = .054) in the absolute than in the extended indication group, there was no between-group difference in the local recurrence rate (0.9% vs 1.1%; P = .783) at a median follow-up period of 32 months (interquartile range 22-48 months). In the extended indication group, ESD resulted in a significantly higher complete resection rate than EMR (83.0% vs 91.1%; P = .006). LIMITATIONS: Retrospective study. CONCLUSION: ESD in the extended indication group showed acceptable clinical outcomes with a relatively high complete resection rate and a low local recurrence rate.
    [Abstract] [Full Text] [Related] [New Search]